IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BELICCHI, MARZIA LAURA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.355
NA - Nord America 7.211
AS - Asia 6.800
SA - Sud America 664
AF - Africa 184
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 10
Totale 23.251
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.881
GB - Regno Unito 2.450
CN - Cina 2.197
SG - Singapore 2.089
DE - Germania 1.268
IT - Italia 1.166
SE - Svezia 974
RU - Federazione Russa 668
HK - Hong Kong 600
BR - Brasile 468
VN - Vietnam 417
IN - India 403
UA - Ucraina 361
NL - Olanda 339
FR - Francia 335
CA - Canada 258
TR - Turchia 256
KR - Corea 217
BD - Bangladesh 212
FI - Finlandia 211
IE - Irlanda 206
EU - Europa 161
CI - Costa d'Avorio 90
PL - Polonia 87
CO - Colombia 82
JP - Giappone 80
ID - Indonesia 76
GR - Grecia 59
AR - Argentina 44
BE - Belgio 43
ES - Italia 38
MX - Messico 38
IQ - Iraq 33
DK - Danimarca 28
IR - Iran 28
UZ - Uzbekistan 28
AU - Australia 22
PK - Pakistan 22
CH - Svizzera 21
RO - Romania 21
PH - Filippine 20
MA - Marocco 19
ZA - Sudafrica 19
EC - Ecuador 18
VE - Venezuela 16
IL - Israele 15
TW - Taiwan 15
AT - Austria 12
CL - Cile 11
MY - Malesia 10
TH - Thailandia 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
LB - Libano 9
PY - Paraguay 9
SA - Arabia Saudita 9
JM - Giamaica 8
KE - Kenya 8
PE - Perù 8
PT - Portogallo 8
SC - Seychelles 8
NP - Nepal 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 6
LT - Lituania 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
KZ - Kazakistan 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
AL - Albania 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LU - Lussemburgo 4
LY - Libia 4
NZ - Nuova Zelanda 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
AO - Angola 3
BH - Bahrain 3
ET - Etiopia 3
LV - Lettonia 3
NG - Nigeria 3
RS - Serbia 3
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
KG - Kirghizistan 2
MD - Moldavia 2
MU - Mauritius 2
Totale 23.374
Salva come PNG Salva come JPEG
Città #
Southend 2.199
Singapore 1.262
Ashburn 701
Chandler 656
Hong Kong 571
Beijing 491
San Jose 406
Milan 363
Frankfurt am Main 341
Seattle 341
Princeton 288
Jacksonville 277
Wilmington 251
Dallas 245
Dublin 201
Council Bluffs 198
Mountain View 169
Toronto 160
Bengaluru 159
Los Angeles 158
Nanjing 157
Redmond 157
Santa Clara 156
Ann Arbor 141
Fairfield 134
Moscow 129
Ho Chi Minh City 124
Lauterbourg 120
Munich 115
New York 110
Boardman 105
Woodbridge 102
Des Moines 99
Sakarya 99
Buffalo 93
Dearborn 93
Hanoi 93
Phoenix 93
Shanghai 91
Abidjan 89
Helsinki 87
Guangzhou 85
Andover 77
Warsaw 76
Medford 75
Serra 74
Bogotá 71
Houston 70
Tianjin 61
Tokyo 57
Jinan 52
Athens 51
São Paulo 49
Rome 48
Cambridge 46
Changsha 46
Nanchang 46
Shenyang 46
Hanover 42
Somerville 41
Turin 38
Brussels 37
Hefei 37
Jakarta 37
Columbus 35
Eitensheim 35
Sunnyvale 35
Chicago 33
Fuzhou 33
Berlin 31
Hangzhou 31
Bitonto 30
Cangzhou 30
Zhengzhou 29
Mumbai 28
Redwood City 28
San Diego 28
Hebei 27
Shenzhen 26
London 25
Montreal 23
Nuremberg 23
Ottawa 23
Quanzhou 23
Grafing 22
Hamburg 22
The Dalles 22
Falls Church 21
Kunming 21
Odernheim 21
Roxbury 21
Dong Ket 20
Atlanta 19
Falkenstein 19
Seoul 19
Auburn Hills 18
Da Nang 18
Istanbul 18
Naples 18
Nürnberg 18
Totale 13.979
Salva come PNG Salva come JPEG
Nome #
Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models 454
Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy 375
CD133+ cells isolated from various sources and their role in future clinical perspective 345
Modificazione genica di cellule staminali distrofiche allo scopo di trapianto autologo nella distrofia muscolare di Duchenne 329
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases 297
Preliminary evidences of safety and efficacy of flavonoids- and omega 3-based compound for muscular dystrophies treatment: a randomized double-blind placebo controlled pilot clinical trial. 297
Effects of rituximab in two patients with dysferlin-deficient muscular dystrophy 281
Expression of CD20 reveals a new store-operated calcium entry modulator in skeletal muscle 280
T and b lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse 277
Autologous intramuscular transplantation of engineered satellite cells induces exosomemediated systemic expression of Fukutin-Related Protein and rescues disease phenotype in a murine model of Limb-Girdle Muscular Dystrophy Type 2I. 272
Rest is required for the regenerative response of skeletal muscle 258
Skin-derived stem cells transplanted into resorable guides provide functional nerve regeneration after sciatic nerve resection 253
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 251
Correlation of circulanting CD133+ progenitor subclasses with a Mild phenotype in Duchenne Muscular dystrophy patients 246
Stem cells and muscular dystrophies 246
Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia 246
Characterization of muscle-specific expression of miRNAs in duchenne muscular dystrophy 244
Generation of the Becker muscular dystrophy patient derived induced pluripotent stem cell line carrying the DMD splicing mutation c.1705-8 T>C 243
Morphological modifications of resected sciatic nerve after autologous transplantation of skin-derived stem cells into resorable guides. 234
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 233
Autologous transplantation of skin-derived stem cells and functional nerve regeneration after a peripheral nerve lesion 233
Combining Stem Cell and Exon Skipping Approach to Treat Muscular Dystrophies 233
Interstitial Cell Remodeling Promotes Aberrant Adipogenesis in Dystrophic Muscles. 230
VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation 228
Functional and structural modifications of dystrophic muscles after autologous transplantation of muscle-derived AC133+ stem cells 227
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 223
Impact of Muscular Dystrophy on the Regenerative Properties of interstitial Muscle Cells 221
CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells 220
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 219
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 218
Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells 216
Isolation and characterization of cells coexpressing endothelial progenitors and parathyroid specific genes from human adult normal and tumoral parathyroids 215
Defective dystrophic thymus determines degenerative changes in skeletal muscle 214
Il trapianto di cellule staminali autologhe derivate da cute in guide tubolari riassorbibili favorisce la rigenerazione assonale nelle lesioni del nervo periferico 212
Heterogeneous tumourogenic ability of human brain tumour derived neurospheres 207
Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy 206
Stem Cell Salvage of injured peripheral nerve 206
Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle 205
Autologous transplantation of bone marrow-derived CD133+ stem cells in facioscapulohumeral dystrophy 205
Heterogeneous tumorigenic capacity of human brain tumor derived neurospheres 204
Development of a new technique for muscle tissues-stem cells co-colture 204
Autologous transplantation of AC133+ stem cells in Duchenne muscular Dystrophy : preclinical and clinical evidences 202
Some applications of nanotechnologies in stem cells research 200
Human fetal CD133+ skeletal muscle cells expressing pericyte merkers generate muscle and endothelial cells and repair dystrophic muscle tissues. 199
Difference in myogenic properties of the blood-derived AC133+ stem cells subpopulation isolated from normal and dystrophic tissues 197
Role of skin derived stem cells in peripheral nerve regeneration 196
Perspectives of Stem Cell Therapy in Duchenne Muscular Dystrophy 196
Myogenic potential of human circulating AC133+ stem cells in murine dystrophic skeletal muscle 195
Cellule staminali e rigenerazione muscolare 195
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy 193
Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands 192
Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection 191
Cell Therapy of Muscular Dystrophy with Engineered CD133+ Cells 191
Blood-derived CD133+ stem cells from normal and dystrophic tissues: a comparative study with clinical applications 190
Autologous transplantation of AC133+ stem cells in Duchenne muscular Dystrophy : preclinical and clinical evidences 190
Cell Theraphy of Muscolar Dystrophy with Engineered CD133+Cell 190
In Vivo Tracking of Stem cell by Nanotechnologies : Future Prospect for Mouse to Human Translation 190
Combining multiple therapeutic strategies for Friedreich’s ataxia (FRDA): antioxidant metallic nanoclusters as coadjuvants for gene and stem cell therapy 189
In vitro and In Vivo mesenchymal stem cells neurothrophin production but limited neuronal differantiation 188
Full-length dysferlin expression driven by engineered human dystrophic blood-derived CD133+ stem cells 186
MicroRNA-206 is upregulated in an animal model of Duchenne Muscular Distrophy. 185
Absence of T and B lymphocytes modulates dystrophic features in dysferlin deficient animal model 184
Autologous Transplantation of Ac133+ stem cells in Duchenne Muscular Dystrophy 183
Development of new technologies Including myogenic differentiation of human circulating CD133+cells 183
Combining Gene and Stem Cell therapy in the Treatment of Dysferlinophaties 182
Ex vivo expansion of human circulating CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 181
Differential Activativation of CD20-Related Signalling Pathway Results in Distinct Differentiation Behaviour of Normal and DMD Circulating CD133+ Stem Cells 181
Preclinical experience and perspectives of a clinical trial using cD133 stem cells 178
Autologous skin-derived stem cells and platelet-rich plasma as treatment for traumatic spinal cord injury 176
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 175
Ex vivo expansion of human circulanting CD133+promising tool for cell-based therapeutic approaches in muscular dystrophy 173
Muscular dystrophies therapies by engineered stem cells 173
Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies. 172
Ex vivo expansion of peripheral blood CD133+ progenitors cells: promising tool for cell-based therapeutic approaches in muscular dystrophy. 170
Development of New technologies Inducing Myogenic Differentiation of Human Circulating CD133+ Cells 169
Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51–53 of the dystrophin gene (CCMi003-A) 169
Muscle-specific microRNAs (mirnas) in Duchenne Muscular Distrophy (DMD). 168
Proliferation and clonal characterization of human muscle derived CD133+ positive stem cells define an intrinsic heterogeneity 168
Absence of T and B lymphocytes enhances skeletal muscle regeneration and ameliorates dystrophic pathology in dysferlin deficient animal model 168
Proliferation and Clonal Analysis of Muscle Derived CD133+ Stem Cell Subpopulations Define a Depletion of Mesenchymal Population in DMD Patients 168
Autologous transplantation of engineered muscle-derived CD133+ stem cells 167
Myogenic differentiation potential of CD133+ stem cells isolated from various sources 165
Muscle Cell Sheet-polymer Film generation and Transplantation for the Treatment of Muscular Dystrophy 164
Combining Stem Cells and Exon-Skipping and Approch to Treat Muscular Dystrophies 163
In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled CD133+ stem cell tropism to dystrophic muscle tissues using micro-CT imaging 162
CD133+ Cells for the Treatment of Degenerative Diseases : update and perspectives 161
Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-Related Protein and rescues disease phenotype in a murine model of Limb-Girdle Muscular Dystrophy Type 2I 161
Polyglycolic acid–polylactic acid scaffold response to different stem cell in-vitro cultures analysed by x-ray synchrotron radiation phase-contrast computed microtomography 160
Myogenic differentiation of galectin-1 pretreated human fetal mesenchymal stem cells after intra-arterial injection into dystrophic mice 159
Human Fetal CD133+ Muscle Cells Expressing Perycite Markers Repair Dystrophic Muscle Tissue. 156
Rescue of human dystrophin after transplantation of exon-skipping-engineered DMD stem cells in a dystrophic animal model 154
Abundance of Circulating Progenitors with Myo-Endothelial Potential Correlates with a Mild Phenotype in Patients Affected by Duchnne Muscular Dystrophy 154
Effective high-throughput isolation of enriched platelets and circulating pro-angiogenic cells to accelerate skin-wound healing 153
Réhabilitation de la dystrophine humaine dans le modèle scid/mdx après greffe de cellules souches de patients DMD corrigées par saut d’exon 152
Perturbation of calcium handling in CD133+ stem cells isolated from DMD blood 152
Autologous skin derived stem cells and platelet-rich plasma as treatment for Traumatic spinal cord injury 152
X-Ray Synchrotron-Radiation Phase-Contras Analysis of Human and Mouse Progenitors in Culture on Engineering Scaffolds 148
Evaluation of labelling efficiency of Tc-99m complexes in human circulating CD133+ Stem Cells. 148
Stem cell-mediated exon skipping of the dystrophin gene by the bystander effect 148
Stem Cell Tracking by Nanotechnologies 147
Totale 20.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.831
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021522 0 0 0 0 0 0 0 0 0 0 417 105
2021/20221.711 124 77 48 104 89 134 134 53 308 116 165 359
2022/20232.441 358 280 215 272 286 410 32 176 283 17 78 34
2023/20241.328 47 86 66 88 385 80 63 59 52 86 121 195
2024/20253.343 144 315 75 409 265 104 156 315 145 330 278 807
2025/20266.281 740 393 567 523 656 451 818 360 657 564 552 0
Totale 24.445